Figure 5 | Scientific Reports

Figure 5

From: A real-world study assessing the impact of retinal fluid on visual acuity outcomes in patients with neovascular age-related macular degeneration in Korea

Figure 5The alternative text for this image may have been generated using AI.

Visual acuity change by absence/presence of retinal fluid at month 3 (cohort 1). ETDRS, Early Treatment Diabetic Retinopathy Study; IRF, intraretinal fluid; RPE, retinal pigment epithelium; SE, standard error; SRF, subretinal fluid; VA, visual acuity. P value analyzed for difference between presence and absence of retinal fluid groups (Wilcoxon signed-rank test). *P < .05,**P < .01,***P < .001. The patient eyes were divided into the presence or absence of fluid at Month 3 and change in VA was stratified of those groups at all subsequent time points.

Back to article page